Annual Revenue
$2.98 B
-$1.16 B-27.98%
December 31, 2024
Summary
- As of March 14, 2025, BNTX annual revenue is $2.98 billion, with the most recent change of -$1.16 billion (-27.98%) on December 31, 2024.
- During the last 3 years, BNTX annual revenue has fallen by -$19.48 billion (-86.74%).
- BNTX annual revenue is now -86.74% below its all-time high of $22.45 billion, reached on December 31, 2021.
Performance
BNTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.27 B
-$100.56 M-7.35%
December 31, 2024
Summary
- As of March 14, 2025, BNTX quarterly revenue is $1.27 billion, with the most recent change of -$100.56 million (-7.35%) on December 31, 2024.
- Over the past year, BNTX quarterly revenue has dropped by -$100.56 million (-7.35%).
- BNTX quarterly revenue is now -82.33% below its all-time high of $7.18 billion, reached on September 30, 2021.
Performance
BNTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.98 B
-$324.27 M-9.81%
December 31, 2024
Summary
- As of March 14, 2025, BNTX TTM revenue is $2.98 billion, with the most recent change of -$324.27 million (-9.81%) on December 31, 2024.
- Over the past year, BNTX TTM revenue has dropped by -$324.27 million (-9.81%).
- BNTX TTM revenue is now -88.99% below its all-time high of $27.06 billion, reached on March 31, 2022.
Performance
BNTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BNTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | -7.3% | -9.8% |
| 3 y3 years | -86.7% | -7.3% | -9.8% |
| 5 y5 years | +2349.2% | +1507.0% | +1498.4% |
BNTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.7% | at low | -82.3% | +815.4% | -89.0% | +2.4% |
| 5 y | 5-year | -86.7% | +2349.2% | -82.3% | +4049.7% | -89.0% | +2351.6% |
| alltime | all time | -86.7% | +4168.4% | -82.3% | +5248.4% | -89.0% | >+9999.0% |
BioNTech SE Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.98 B(-28.0%) | $1.27 B(-7.3%) | $2.98 B(-9.8%) |
| Sep 2024 | - | $1.37 B(+887.9%) | $3.30 B(+13.5%) |
| Jun 2024 | - | $138.58 M(-32.0%) | $2.91 B(-1.5%) |
| Mar 2024 | - | $203.77 M(-87.2%) | $2.95 B(-28.3%) |
| Dec 2023 | $4.13 B(-77.4%) | $1.59 B(+63.4%) | $4.12 B(-40.3%) |
| Sep 2023 | - | $974.79 M(+433.1%) | $6.90 B(-26.7%) |
| Jun 2023 | - | $182.87 M(-86.7%) | $9.42 B(-25.5%) |
| Mar 2023 | - | $1.37 B(-68.6%) | $12.64 B(-31.4%) |
| Dec 2022 | $18.26 B(-18.7%) | $4.37 B(+25.5%) | $18.42 B(-9.6%) |
| Sep 2022 | - | $3.49 B(+2.4%) | $20.37 B(-15.3%) |
| Jun 2022 | - | $3.40 B(-52.4%) | $24.06 B(-11.1%) |
| Mar 2022 | - | $7.15 B(+13.0%) | $27.06 B(+20.9%) |
| Dec 2021 | $22.45 B | $6.33 B(-11.8%) | $22.37 B(+36.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $7.18 B(+12.2%) | $16.46 B(+75.9%) |
| Jun 2021 | - | $6.40 B(+159.2%) | $9.36 B(+211.4%) |
| Mar 2021 | - | $2.47 B(+499.4%) | $3.01 B(+429.8%) |
| Dec 2020 | $550.80 M(+353.0%) | $411.82 M(+421.7%) | $567.25 M(+204.3%) |
| Sep 2020 | - | $78.93 M(+71.9%) | $186.43 M(+33.8%) |
| Jun 2020 | - | $45.92 M(+50.2%) | $139.37 M(+13.9%) |
| Mar 2020 | - | $30.57 M(-1.4%) | $122.41 M(+0.7%) |
| Dec 2019 | $121.58 M(-19.3%) | $31.00 M(-2.7%) | $121.55 M(-25.6%) |
| Sep 2019 | - | $31.87 M(+10.0%) | $163.31 M(+5.3%) |
| Jun 2019 | - | $28.97 M(-2.5%) | $155.16 M(+23.0%) |
| Mar 2019 | - | $29.71 M(-59.2%) | $126.19 M(+30.8%) |
| Dec 2018 | $150.64 M(+115.9%) | $72.77 M(+206.8%) | $96.49 M(+306.8%) |
| Sep 2018 | - | $23.72 M | $23.72 M |
| Dec 2017 | $69.76 M | - | - |
FAQ
- What is BioNTech SE annual revenue?
- What is the all time high annual revenue for BioNTech SE?
- What is BioNTech SE annual revenue year-on-year change?
- What is BioNTech SE quarterly revenue?
- What is the all time high quarterly revenue for BioNTech SE?
- What is BioNTech SE quarterly revenue year-on-year change?
- What is BioNTech SE TTM revenue?
- What is the all time high TTM revenue for BioNTech SE?
- What is BioNTech SE TTM revenue year-on-year change?
What is BioNTech SE annual revenue?
The current annual revenue of BNTX is $2.98 B
What is the all time high annual revenue for BioNTech SE?
BioNTech SE all-time high annual revenue is $22.45 B
What is BioNTech SE annual revenue year-on-year change?
Over the past year, BNTX annual revenue has changed by -$1.16 B (-27.98%)
What is BioNTech SE quarterly revenue?
The current quarterly revenue of BNTX is $1.27 B
What is the all time high quarterly revenue for BioNTech SE?
BioNTech SE all-time high quarterly revenue is $7.18 B
What is BioNTech SE quarterly revenue year-on-year change?
Over the past year, BNTX quarterly revenue has changed by -$100.56 M (-7.35%)
What is BioNTech SE TTM revenue?
The current TTM revenue of BNTX is $2.98 B
What is the all time high TTM revenue for BioNTech SE?
BioNTech SE all-time high TTM revenue is $27.06 B
What is BioNTech SE TTM revenue year-on-year change?
Over the past year, BNTX TTM revenue has changed by -$324.27 M (-9.81%)